Literature DB >> 19503107

Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.

Karel Otero1, Isaiah R Turnbull, Pietro Luigi Poliani, William Vermi, Elisa Cerutti, Taiki Aoshi, Ilaria Tassi, Toshiyuki Takai, Samuel L Stanley, Mark Miller, Andrey S Shaw, Marco Colonna.   

Abstract

Macrophage colony-stimulating factor (M-CSF) influences the proliferation and survival of mononuclear phagocytes through the receptor CSF-1R. The adaptor protein DAP12 is critical for the function of mononuclear phagocytes. DAP12-mutant mice and humans have defects in osteoclasts and microglia, as well as brain and bone abnormalities. Here we show DAP12 deficiency impaired the M-CSF-induced proliferation and survival of macrophages in vitro. DAP12-deficient mice had fewer microglia in defined central nervous system areas, and DAP12-deficient progenitors regenerated myeloid cells inefficiently after bone marrow transplantation. Signaling by M-CSF through CSF-1R induced the stabilization and nuclear translocation of beta-catenin, which activated genes involved in the cell cycle. DAP12 was essential for phosphorylation and nuclear accumulation of beta-catenin. Our results provide a mechanistic explanation for the many defects of DAP12-deficient mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19503107      PMCID: PMC4004764          DOI: 10.1038/ni.1744

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

Review 1.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.

Authors:  Toshio Kitamura; Yuko Koshino; Fumi Shibata; Toshihiko Oki; Hideaki Nakajima; Tetsuya Nosaka; Hidetoshi Kumagai
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084

Review 2.  Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis.

Authors:  J Xaus; M Comalada; A F Valledor; M Cardó; C Herrero; C Soler; J Lloberas; A Celada
Journal:  Immunobiology       Date:  2001-12       Impact factor: 3.144

3.  An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation.

Authors:  Günter W Klappacher; Victoria V Lunyak; David B Sykes; Dominique Sawka-Verhelle; Julien Sage; Gyan Brard; Sally D Ngo; Denise Gangadharan; Tyler Jacks; Mark P Kamps; David W Rose; Michael G Rosenfeld; Christopher K Glass
Journal:  Cell       Date:  2002-04-19       Impact factor: 41.582

4.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

5.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Authors:  Xianghong Chen; Fanqi Bai; Lubomir Sokol; Junmin Zhou; Amy Ren; Jeffrey S Painter; Jinhong Liu; David A Sallman; Y Ann Chen; Jeffrey A Yoder; Julie Y Djeu; Thomas P Loughran; Pearlie K Epling-Burnette; Sheng Wei
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

7.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.

Authors:  Juha Paloneva; Tuula Manninen; Grant Christman; Karine Hovanes; Jami Mandelin; Rolf Adolfsson; Marino Bianchin; Thomas Bird; Roxana Miranda; Andrea Salmaggi; Lisbeth Tranebjaerg; Yrjö Konttinen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-06-21       Impact factor: 11.025

8.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.

Authors:  Tomonori Kaifu; Jin Nakahara; Masanori Inui; Kenichi Mishima; Toshihiko Momiyama; Mitsuji Kaji; Akiko Sugahara; Hisami Koito; Azusa Ujike-Asai; Akira Nakamura; Kiyoshi Kanazawa; Kyoko Tan-Takeuchi; Katsunori Iwasaki; Wayne M Yokoyama; Akira Kudo; Michihiro Fujiwara; Hiroaki Asou; Toshiyuki Takai
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

Authors:  Roberta Faccio; Wei Zou; Graziana Colaianni; Steven L Teitelbaum; F Patrick Ross
Journal:  J Cell Biochem       Date:  2003-12-01       Impact factor: 4.429

10.  DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Authors:  Juha Paloneva; Jami Mandelin; Anna Kiialainen; Tom Bohling; Johannes Prudlo; Panu Hakola; Matti Haltia; Yrjo T Konttinen; Leena Peltonen
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

View more
  127 in total

1.  ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling.

Authors:  Daniel B Graham; Holly M Akilesh; Grzegorz B Gmyrek; Laura Piccio; Susan Gilfillan; Julia Sim; Roger Belizaire; Javier A Carrero; Yinan Wang; Gregory S Blaufuss; Gabriel Sandoval; Keiko Fujikawa; Anne H Cross; John H Russell; Marina Cella; Wojciech Swat
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

2.  Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.

Authors:  Wei Zou; Tingting Zhu; Clarissa S Craft; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2010-09-01       Impact factor: 5.285

3.  TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.

Authors:  Karel Otero; Masahiro Shinohara; Haibo Zhao; Marina Cella; Susan Gilfillan; Angela Colucci; Roberta Faccio; F Patrick Ross; Steve L Teitelbaum; Hiroshi Takayanagi; Marco Colonna
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

Review 4.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.

Authors:  Marco Colonna; Yaming Wang
Journal:  Nat Rev Neurosci       Date:  2016-02-25       Impact factor: 34.870

5.  CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation.

Authors:  Luo Zhang; Yiwu Wang; Fengjun Xiao; Shaoxia Wang; Guichun Xing; Yang Li; Xiushan Yin; Kefeng Lu; Rongfei Wei; Jiao Fan; Yuhan Chen; Tao Li; Ping Xie; Lin Yuan; Lei Song; Lanzhi Ma; Lujing Ding; Fuchu He; Lingqiang Zhang
Journal:  Cell Res       Date:  2014-04-29       Impact factor: 25.617

6.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

Review 7.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

Review 8.  The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

Authors:  Jessica A Hamerman; Minjian Ni; Justin R Killebrew; Ching-Liang Chu; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

9.  DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.

Authors:  O Yoshida; S Kimura; L Dou; B M Matta; S Yokota; M A Ross; D A Geller; A W Thomson
Journal:  Am J Transplant       Date:  2014-06-16       Impact factor: 8.086

10.  Phospholipase Cγ1 (PLCγ1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/β-Catenin/CyclinD1 Pathway.

Authors:  Zhengfeng Yang; Seokho Kim; Sahil Mahajan; Ali Zamani; Roberta Faccio
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.